The new stimulant for physiological immune defenses
On 18 September 2020, via Webinar, a presentation washeld to the entire network of FUTURE LIVE …
Pealgyl new food supplement for long-term pelvic pain
On 28-29-30-31 October at the FUTURE LIVE headquarters in Affi (VR), the presentation to the entire …
Although conventional therapies provide satisfactory results in the treatment of acute vaginal Candidiasis, there is still interest in preventing relapse. In this study, conducted on a group of women with vaginal Candidosis the strain of Saccharomyces cerevisiae CNCM I-3856 was effective in the control of vaginal candida proliferation and in the prevention of recurrent vaginal Candidosis. This probiotic yeast is well tolerated and easy to use in oral administration
Saccharomyces cerevisiae CNCM I-3856 as Natural Breakthrough for Vaginal Health: A Clinical Study …
The data suggest that the beneficial effects of this live Saccharomyces cerevisiae are the result of its interference with the expression of the virulence factors of Candida albicans associated with modulation of the host inflammatory response.
Saccharomyces cerevisiae-based probiotic as novel anti-fungal and anti-inflammatory agent for …
Vaginal candidosis is the most common infection and Candida albicans is the main infectious agent. Our data show for the first time that ingredients made up of Saccharomyces cerevisiae, particularly live cells, can exert beneficial effects on an extensive infection of the vaginal mucosa
Therapeutic activity of a Saccharomyces cerevisiae-based probiotic and inactivated whole yeast on …
The new adjuvant for Candida albicans is launched on October 26, 2018
Last October 4th at the Hotel Principe di Lazise, there was a presentation to the entire Future …